Skip to main content
. 2021 Nov 27;234:108897. doi: 10.1016/j.clim.2021.108897

Fig. 1.

Fig. 1

Flowchart of study enrollment and data collection. Patients with AIRD treated with RTX were included in the study. Patients who had RTX stopped or postponed indefinitely during study period were excluded. One patient declined participation in the study. Seventy-two patients were included for chart review and telephone survey. Sixty-three patients completed a full vaccine series and anti-spike antibody data was available for 41 of those patients.